Replies to post #91 on Ocera Therapeutics fka OCRX

[ceps101]

I guess you will only loose $3 per share then.

[DAD2]

Nice to see that they are holding a bullish positive forecast imo.

[Seshet]

PPS Target should be higher than $1 after new results are announced.

TZYM CEO stated...
"We are understandably disappointed with the results of this trial; however, our second Phase 2b trial known as DIGEST is ongoing. In DIGEST we are evaluating a 10 mg dose of TZP-102 administered three times daily before meals, rather than once daily as in the trial just completed. We anticipate announcing top line results for DIGEST in the first half of 2013," said Vipin K. Garg, PhD, President and Chief Executive Officer of Tranzyme.